Raymond James Financial Services Advisors Inc. boosted its position in Henry Schein, Inc. (NASDAQ:HSIC) by 96.1% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,842 shares of the company’s stock after purchasing an additional 2,373 shares during the period. Raymond James Financial Services Advisors Inc.’s holdings in Henry Schein were worth $397,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Intrust Bank NA lifted its position in shares of Henry Schein by 1.1% during the 2nd quarter. Intrust Bank NA now owns 1,219 shares of the company’s stock valued at $223,000 after buying an additional 13 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its position in shares of Henry Schein by 0.3% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 5,894 shares of the company’s stock valued at $1,079,000 after buying an additional 19 shares in the last quarter. YorkBridge Wealth Partners LLC lifted its position in shares of Henry Schein by 5.2% during the 2nd quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock valued at $104,000 after buying an additional 28 shares in the last quarter. Sawtooth Solutions LLC lifted its position in shares of Henry Schein by 2.4% during the 2nd quarter. Sawtooth Solutions LLC now owns 1,347 shares of the company’s stock valued at $247,000 after buying an additional 32 shares in the last quarter. Finally, Wedbush Securities Inc. lifted its position in shares of Henry Schein by 3.8% during the 2nd quarter. Wedbush Securities Inc. now owns 1,600 shares of the company’s stock valued at $293,000 after buying an additional 58 shares in the last quarter. 91.75% of the stock is currently owned by institutional investors and hedge funds.

Shares of Henry Schein, Inc. (NASDAQ HSIC) opened at $67.57 on Friday. The stock has a market capitalization of $11,159.46, a P/E ratio of 19.94, a P/E/G ratio of 2.00 and a beta of 0.99. Henry Schein, Inc. has a 12 month low of $65.28 and a 12 month high of $93.50. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.86 and a current ratio of 1.55.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Monday, November 6th. The company reported $0.87 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.90 by ($0.03). The business had revenue of $3.16 billion for the quarter, compared to the consensus estimate of $3.05 billion. Henry Schein had a net margin of 4.52% and a return on equity of 19.71%. The firm’s revenue for the quarter was up 10.3% compared to the same quarter last year. During the same period last year, the business posted $0.84 EPS. equities analysts forecast that Henry Schein, Inc. will post 3.6 earnings per share for the current fiscal year.

Henry Schein announced that its board has initiated a share buyback program on Monday, September 18th that permits the company to repurchase $400.00 million in outstanding shares. This repurchase authorization permits the company to buy up to 6.3% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s board of directors believes its stock is undervalued.

In related news, Director Barry J. Alperin sold 5,796 shares of Henry Schein stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $70.76, for a total transaction of $410,124.96. Following the sale, the director now owns 48,172 shares of the company’s stock, valued at approximately $3,408,650.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.19% of the stock is currently owned by company insiders.

A number of research analysts have recently weighed in on the company. Royal Bank Of Canada lowered their price objective on Henry Schein from $91.00 to $82.00 and set a “sector perform” rating on the stock in a research report on Tuesday, November 7th. Jefferies Group reaffirmed a “hold” rating and set a $89.00 price objective on shares of Henry Schein in a research report on Friday, October 20th. Credit Suisse Group reaffirmed a “hold” rating and set a $87.50 price objective on shares of Henry Schein in a research report on Tuesday, August 29th. Stephens assumed coverage on Henry Schein in a research report on Tuesday, November 28th. They set an “equal weight” rating and a $76.00 price objective on the stock. Finally, Morgan Stanley cut Henry Schein from an “equal weight” rating to an “underweight” rating and set a $88.00 price objective on the stock. in a research report on Wednesday. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and seven have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $88.36.

ILLEGAL ACTIVITY WARNING: This piece of content was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark laws. The legal version of this piece of content can be read at https://www.thecerbatgem.com/2017/12/08/raymond-james-financial-services-advisors-inc-increases-holdings-in-henry-schein-inc-hsic.html.

Henry Schein Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.